(Report ID: 27003) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 78 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 27003 | Jan, 18, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Lipidil |
Diclofenac Sodium |
Results from eHealthMe: 78 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Liver Disorder | 2 (2.56%) |
Death: 1 (7.69% of total reports)
Cancer: 1 (7.69% of total reports)
| Name | Count (% of total reports) |
1 | Renal Failure | 3 (23.08%) |
2 | Bundle Branch Block Left | 3 (23.08%) |
3 | Drug Ineffective | 3 (23.08%) |
4 | Blood Potassium Increased | 3 (23.08%) |
5 | Blood Creatinine Increased | 3 (23.08%) |
6 | Hyperkalaemia | 2 (15.38%) |
7 | Feeling Abnormal | 2 (15.38%) |
8 | Glossodynia | 2 (15.38%) |
9 | Abnormal Behaviour | 2 (15.38%) |
10 | Stent Occlusion | 1 (7.69%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Voltaren | 8 |
2 | Lasix | 6 |
3 | Plavix | 6 |
4 | Irbesartan | 5 |
5 | Duragesic-100 | 5 |
6 | Bactrim | 5 |
7 | Acarbose | 5 |
8 | Simvastatin | 5 |
9 | Pantoprazole Sodium | 4 |
10 | Insulin Aspart | 4 |
Death: 2 (2.56% of total reports)
Cancer: 2 (2.56% of total reports)
| Name | Count (% of total reports) |
1 | Blood Creatinine Increased | 8 (10.26%) |
2 | Drug Ineffective | 6 (7.69%) |
3 | Pancytopenia | 5 (6.41%) |
4 | Pain | 5 (6.41%) |
5 | Bundle Branch Block Left | 4 (5.13%) |
6 | Sciatica | 4 (5.13%) |
7 | Difficulty In Walking | 4 (5.13%) |
8 | Myalgia | 4 (5.13%) |
9 | Renal Failure | 4 (5.13%) |
10 | Blood Potassium Increased | 4 (5.13%) |
| Name | Count |
1 | Voltaren | 46 |
2 | Tricor | 16 |
3 | Aspirin | 10 |
4 | Irbesartan | 8 |
5 | Pantoprazole Sodium | 8 |
6 | Metformin Hcl | 8 |
7 | Plavix | 8 |
8 | Acarbose | 7 |
9 | Arava | 7 |
10 | Methotrexate | 7 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
